About hVIVO

hVIVO is a contract research organisation specialising in human challenge trials and early phase clinical development. The company accelerates drug development by exposing healthy volunteers to pathogens in controlled quarantine facilities, generating efficacy and safety data faster than traditional field trials. This helps pharmaceutical and biotech companies make informed decisions earlier. hVIVO operates quarantine facilities in London and clinical sites across the UK and Germany, supported by infectious disease laboratories. Serving global clients including seven of the top ten biopharma firms, the company delivers services from preclinical consultancy through Phase III trials, bringing vaccines and antivirals to patients sooner.